Mobocertinib is approved by the US FDA which is now recommended in the management of lung cancer. It is an oral EGFR tyrosine kinase inhibitor. Exkivity is prescribed for NSCLC patients with EGFR Exon 20 insertion mutations. Being an oral medication with promising outcomes, this medication may be preferred over other options currently available in this setting. As of now, it is approved for the use in adult patients only. Its safety and efficacy in pediatric patients are not established as yet. This drug is developed and promoted by Takeda Pharmaceutical Company. It is commercially available as Exkivity 40 mg Capsules, available in a pack of 120 Capsules. Mobocertinib Price in India is not standardized and can be determined based on the prevailing global cost factors.
Exkivity 40 mg Capsules – US FDA and EMA Approval status
Takeda has secured US FDA approval for Exkivity (Mobocertinib) in Septeber 2021. It is relatively a new drug to be approved. Patients who are progressed on or after a platinum- based chemotherapy are eligible for its use. The overall response rate was the key efficacy outcome that led to its accelerated approval by the FDA. More regulatory approvals are expected in the future.
- Oncologists recommend Exkivity 40 mg capsules as per the standard dosage recommendations. Under normal circumstances, adult patients are advised for 160 mg per day. Dose modifications are determined by the treating physicians based on the tolerability and response.
- Exkivity cost would matter when the treatment choice is made. Therefore, accurate dosage recommendation would help patients to evaluate all the relevant factors before considering treatment with Mobocertinib.
Mobocertinib Cost in India – Access related information for patients
Exkivity cost in India is worked out from the viewpoint of patient’s specific requirements. The limitation in terms of lack of easy access within the country impact the price of Exkivity in India. It is common for patients to look for various options that are economical as well as reliable. Even though any product can be searched online with many options available, it is still a difficult task for patients to find the right supplier with proven credentials. It is a good
practice to check from the treating physicians if they can help with credible references. Often the references about lifesaving medicines by the hospital teams are more reliable. Lifesaving medicines that are specifically prescribed with an objective of prolonging survival need to be procured fast. Keeping the cost related factors aside and looking from theperspective of health, speedy delivery should be an important criterion. The availability and allocation from the international markets also play the crucial part in early access.
Sourcing Exkivity (Mobocertinib) in India through reliable sources
Lifesaving medicines should be shipped with certain specifications. Many of them are temperature controlled and the supply chain should be planned by keeping all the sensitivities in mind. Before ordering any medicine from international sources, it is most important to procure the import permit from CDSCO online. It can be done by the patients by submitting a valid prescription by a registered physician, preferably an Oncologist when it comes to cancer medications. Companies that are experienced in handling the import of specialized medicines like Exkivity (Mobocertinib) in India should be counted on for hassle free delivery.
Contact Noel Biotech – +91 9677010046 / +91 992977766; firstname.lastname@example.org